Contraception: Securing reproductive rights Fiala C, Weeks A, Safar P. Lancet. 2004 Mar 20;363(9413):989-90 Abortion: Evaluation of Early Medical Abortion (EMA) Pilot Sites Roger Ingham and Ellie Lee et al. University of Southampton and Department of Health, London www.dh.gov.uk Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol Aronsson A, Fiala C, Stephansson O, Granath F, Watzer B, Schweer H, Gemzell-Danielsson K. Hum Reprod. 2007 Jul;22(7):1912-8 www.ncbi.nlm.nih.gov Frequently asked clinical questions about medical abortion, WHO, 2006 www.who.int Review of medical abortion using mifepristone in combination with a prostaglandin analogue Fiala C, Gemzel-Danielsson K. Contraception 2006 Jul;74(1):66-86 www.ncbi.nlm.nih.gov Pharmacokinetics of a novel oral slow-release form of misoprostol Fiala C, Aronsson A, Granath F, Stephansson O, Seyberth HW, Watzer B, Gemzell-Danielsson K. Hum Reproduction 2005 Dec;20(12):3414-8 www.ncbi.nlm.nih.gov Effects of slow release misoprostol on uterine contractility in early pregnancy C. Fiala, A. Aronsson, O. Stephansson and K. Gemzell-Danielsson Human Reproduction 2005 Sep;20(9):2648-52. www.ncbi.nlm.nih.gov The effect of non-steroidal anti-inflammatory drugs (NSAIDs) on medical abortion with mifepristone and misoprostol at 13 to 22 weeks gestation C. Fiala, ML. Swahn, O. Stephansson, and K. Gemzell-Danielsson Human Reproduction 2005 Nov;20(11):3072-7 www.ncbi.nlm.nih.gov Abortion in Europe: Are the Laws and Practices patient centered? Christian Fiala Entre Nous magazine, UNFPA/ WHO No. 59 – 2005, page 23-5 download pdf Acceptability of home-use of misoprostol in medical abortion Fiala C, Winikoff B, Helstrom L, Hellborg M, Gemzell-Danielsson K. Contraception. 2004 Nov;70(5):387-92. www.ncbi.nlm.nih.gov Rh-prophylaxis in early abortion Fiala C, Fux M, Gemzell Danielsson K. Acta Obstet Gynecol Scand. 2003 Oct;82(10):892-903. Review www.ncbi.nlm.nih.gov Verifying the effectiveness of medical abortion; ultrasound versus hCG testing Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K. Eur J Obstet Gynecol Reprod Biol. 2003 Aug 15;109(2):190-5. www.ncbi.nlm.nih.gov Medical abortion - where we are in Europe Christian Fiala, Entre Nous magazine, UNFPA/ WHO No 47-48; Autumn 2000: 16-17 Other topics: Misoprostol and the debate over off-label drug use Weeks AD, Fiala C, Safar P British Journal of Obstetrics and Gynaecology. 2005 Mar;112(3):269-72. www.misoprostol.org
|